National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou 310014, PR China; Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, PR China.
National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou 310014, PR China; Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, PR China.
J Biotechnol. 2024 Dec 10;396:10-17. doi: 10.1016/j.jbiotec.2024.10.005. Epub 2024 Oct 11.
The biotransformation of phytosterol into high value steroid intermediates such as 9α-hydroxyandrost-4-ene-3,17-dione (9-OHAD) in Mycolicibacterium is the cornerstone of the steroid pharmaceuticals. However, the limited permeability of the dense mycobacterial cell wall severely hinders the efficient transportation of phytosterol and their bioconversion to 9-OHAD. In this study, we disrupted the genetic pathways involved in trehalose biosynthesis, trehalose recycle and by-product formation, leading to alterations in cell wall formation, cell permeability and 9-OHAD productivity. This manipulation led to an increase of 63.7% in the yield of 9-OHAD, reaching 10.8 g/L at a phytosterol concentration of 20 g/L in shake flask. The enhancement of cell permeability and 9-OHAD production were achieved through the deletion of genes TreS, TreY, OtsA, LpqY, and SugC, as well as the inactivation of regulator PadR. Notably, it was found that the increase in TMM content of cell wall components via TLC analysis directly affected the distribution of 9-OHAD within and outside the cell, ultimately leading to an increase in extracellular production of 9-OHAD from 12% to 32.1%. Therefore, this study provides with an effective strategy for enhancing 9-OHAD production by increasing cell permeability while minimizing by-product 4-AD formation.
植物甾醇生物转化为高价值甾体中间体,如 9α-羟基雄甾-4-烯-3,17-二酮(9-OHAD),是甾体药物的基石。然而,致密分枝杆菌细胞壁的有限通透性严重阻碍了植物甾醇的有效运输及其向 9-OHAD 的生物转化。在本研究中,我们破坏了涉及海藻糖生物合成、海藻糖循环和副产物形成的遗传途径,导致细胞壁形成、细胞通透性和 9-OHAD 生产力的改变。这种操作导致 9-OHAD 的产量增加了 63.7%,在摇瓶中 20g/L 植物甾醇浓度下达到 10.8g/L。通过敲除 TreS、TreY、OtsA、LpqY 和 SugC 基因以及失活调节剂 PadR,实现了细胞通透性的增强和 9-OHAD 的生产。值得注意的是,通过薄层色谱分析发现细胞壁成分 TMM 含量的增加直接影响 9-OHAD 在细胞内外的分布,最终导致细胞外 9-OHAD 的产量从 12%增加到 32.1%。因此,本研究通过增加细胞通透性同时最小化副产物 4-AD 的形成,提供了一种有效提高 9-OHAD 产量的策略。